Polycystic Ovary Syndrome(PCOS). Newborn light for gestational age, 2000-2499 grams
Conditions
Interventions
Intervention 1: Intervention Group: Includes 25 Patients Who Will be Randomly Selected and Treated With Placebo Orally For Two Months. Intervention 2: Control Group: Includes 25 Patients Who Will be T
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age of Admission 25 to 60 Years Body Mass Index Less than or Equal to 30 Diagnosis of Women with Polycystic Ovarian Syndrome Defined as Presence of 2 Characteristics of the Following 3 Characteristics: Oligoavulation or non Ovulation, Biochemical and / or Clinical Evidence of Hyperandrogenism, Features of Transvaginal Ultrasonography Representing More than 12 Immature Follicles Less than 10 mm Per Ovary
Exclusion criteria
Exclusion criteria: Unwillingness of Patients to Participate in the Study Kidney Disease, Coronary Arteries, Acute and Chronic Pulmonary Inflammation, Short Stomach and Intestine Syndrome, Allergies Pregnancy and Lactation Traveling for More than 2 Weeks Smokers Use of Food Supplements Anti-Inflammatory Drugs Use of any Antioxidant Supplement in the Last 3 Months Use of Immunosuppressive Drugs Follow Certain Diets Change the Diet or Decide to Lose Weight
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HDL. Timepoint: 0-60. Method of measurement: Laboratory Kits.;LDL. Timepoint: 0-60. Method of measurement: Laboratory Kits.;T.G. Timepoint: 0-60. Method of measurement: Laboratory Kits.;FBS. Timepoint: 0-60. Method of measurement: Laboratory Kits.;Insulin resistance. Timepoint: 0-60. Method of measurement: Laboratory Kits.;Insulin. Timepoint: 0-60. Method of measurement: Laboratory Kits. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPegah Sedighii
Ahvaz University of Medical Sciences
Outcome results
None listed